MV TELEGRAPH DAILY NEWS
Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out more broadly in the coming years, putting them at risk of developing more severe disease as they wait months or perhaps years for a diagnosis. The U.S. health-care system is …
Continue reading “Sufferers might wait years for brand new medication”
patients who have taken Eli Lilli‘s weight-loss drug, Tirzepatide, lost an average of up to 34 pounds, or 16% of her body weight, the company said in clinical trial results released Thursday. Eli Lilly plans to complete its application for approval of the drug by the Food and Drug Administration in the coming weeks, and …
Continue reading “Eli Lilly weight reduction drug tirzepatide knowledge launched”
Carl Icahn speaks at Delivering Alpha in New York on September 13, 2016. David A Grogan | CNBC Carl Icahn called on Friday illuminas first-quarter results were “very disappointing” and slammed the DNA sequencing company’s new cost-cutting plans. The activist investor, which owns a 1.4% stake in Illumina, is in a heated proxy battle with …
Continue reading “Carl Icahn slams Illumina’s Q1 outcomes and cost-cutting plan”
note on Thursday reported first-quarter sales and adjusted earnings that beat Wall Street expectations, despite a sharp drop in sales of its Covid antiviral treatment molnupiravir. Sales of molnupiravir collapsed to $392 million during the period, down 88% from the $3.2 billion reported for the first quarter of 2022. Merck said the decline was primarily …
Medical bottles and syringes with the logo of Eli Lilly and Company are seen on a screen in the background in this illustrative photo taken in Krakow, Poland, on November 10, 2022. Jakub Porzycki | Nurphoto | Getty Images Eli LilliFirst-quarter results missed expectations on Thursday, but the drug company raised its full-year guidance. Before …
Chiquita Brooks-LaSure testifies before the Senate Finance Committee during her nomination hearing for Administrator of the Centers for Medicare & Medicaid Services in Washington on Thursday, April 15, 2021. Caroline Brehmann | CQ Roll Call, Inc. | Getty Images Medicare will cover new Alzheimer’s treatment Leqembi for all patients eligible under the drug’s label when …
Continue reading “Medicare will take over Alzheimer’s remedy Leqembi after FDA approval”
A building on the Illumina World Headquarters campus is shown on September 1, 2021 in San Diego, California. Mike Blake | Reuters Enlightenment on Tuesday unveiled cost-cutting plans to improve the DNA sequencing company’s shrinking margins. The plans aim to cut Illumina’s annualized spend by more than $100 million starting later this year, according to …
Continue reading “Illumina plans to chop prices because it faces shrinking margins”
Johnson & Johnson products for sale in New York. Scott Mill | CNBC Johnson&Johnson will price shares of its consumer-health spinoff Kenvue at $20 to $23 in an IPO later this year, the company said in a regulatory filing filed Monday. The spinoff, which would be valued at around $40 billion at this share range, …
Continue reading “J&J broadcasts IPO costs for shopper spinoff Kenvue”
Close-up of a yellow fever mosquito biting human skin. It is a Culicidae vector of malaria, yellow fever, chikungunya, dengue and Zika virus in Brazil locally known as Mosquito da Dengue. João Paulo Burini | moment | Getty Images Nigeria this week joined Ghana in tentatively approving a new malaria vaccine being developed by Oxford …
In this photo illustration, Novo Nordisk insulin pens are on display on March 14, 2023 in Miami, Florida. Joe Raedle | Getty Images A bipartisan Senate bill introduced this week would limit the price of insulin to $35 a month for people with private insurance. The bill, drafted by Sens. Jeanne Shaheen, DN.H., and Susan …
Continue reading “Senate invoice proposes insulin worth cap for diabetes sufferers”
